Adoptive Cell Therapy | GRACE :: Treatments & Symptom Management

GRACE :: Treatments & Symptom Management

adoptive cell therapy

The Future of Cancer Immunotherapy: Combination Treatments

Published April 14, 2015 | By GRACE Video | Leave a comment

Immunotherapy Forum Video #29: In part 2 of 2, Dr. Jason Luke discusses treating cancer with immunotherapy and another drug, such chemotherapy or targeted therapies, as well as what we know about biomarkers that predict if an immunotherapeutic will work.

Podcast: Play in new window | Download (Duration: 11:12 — 45.8MB)

Posted in Cancer Treatments, Core Concepts, Gene Profiles/Molecular Signatures, General Lung Cancer Issues, GRACECast, Immune/Vaccine-based therapies, Immunotherapy, Kidney Cancer (RCC), Lung Cancer, Targeted therapies, Targeted Therapies, Activity and Side Effects, Treatment, Treatments & Symptom Management | Tagged adoptive cell therapy, Avastin, Bevacizumab, biomarkers, BRAF, CAR-T cells, cetuximab, Chemotherapy, combination therapy, Current Clinical Trials, Cyramza, dabrafenib, Dr. Jason Luke, EGFR, Erbitux, IL-2, immune therapy, immunotherapy, indoximod, Interleukin-2, ipilimumab, Keytruda, kidney cancer, Lung Cancer, Mekinist, melanoma, PD-1, PD-L1, pembrolizumab, radiation, ramucirumab, RCC, renal cell carcinoma, Side Effects, Tafinlar, Targeted Therapy, toxicities, trametinib, University of Chicago, vaccines, vemurafenib, YERVOY, Zelboraf | Leave a comment

Archives


Follow us on...		Mission \| Disclaimer	Profile \| GRACEcasts \| DONATE

Copyright ©2018 GRACE - All Rights Reserved